Related references
Note: Only part of the references are listed.Examining the Use of Real-World Evidence in the Regulatory Process
Brett K. Beaulieu-Jones et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Barriers and facilitators to conduct high-quality, large-scale safety and comparative effectiveness research: The Biologics and Biosimilars Collective Intelligence Consortium experience
Catherine M. Lockhart et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2020)
Treatment patterns and outcomes in pancreatic cancer: Retrospective claims analysis
Yunes Doleh et al.
CANCER MEDICINE (2020)
Evolving trends in the management of high-intermediate risk endometrial cancer in the United States
Sara J. Zakem et al.
GYNECOLOGIC ONCOLOGY (2019)
Cancer treatment and survivorship statistics, 2019
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Novel Data Linkages to Characterize Palliative and End-Of-Life Care: Challenges and Considerations
Cara L. McDermott et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2019)
Temporal trends in management and outcomes of testicular cancer: A population-based study
Michael J. Leveridge et al.
CANCER (2018)
Can Chemotherapy-Related Acute Care Visits Be Accurately Identified in Administrative Data?
Monika K. Krzyzanowska et al.
JOURNAL OF ONCOLOGY PRACTICE (2018)
Accuracy of administrative databases in detecting primary breast cancer diagnoses: a systematic review
Iosief Abraha et al.
BMJ OPEN (2018)
Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician
Lawrence Blonde et al.
ADVANCES IN THERAPY (2018)
Performance of claims-based algorithms for identifying incident thyroid cancer in commercial health plan enrollees receiving antidiabetic drug therapies
Donnie Funch et al.
BMC HEALTH SERVICES RESEARCH (2017)
Sensitivity of Medicare Claims to Identify Cancer Recurrence in Elderly Colorectal and Breast Cancer Patients
Joan L. Warren et al.
MEDICAL CARE (2016)
Sensitivity of Medicare Claims Data for Measuring Use of Standard Multiagent Chemotherapy Regimens
Elizabeth B. Lamont et al.
MEDICAL CARE (2014)
Validation of Electronic Data on Chemotherapy and Hormone Therapy Use in HMOs
Debra P. Ritzwoller et al.
MEDICAL CARE (2013)
Identification of metastatic cancer in claims data
Beth L. Nordstrom et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2012)
Impact of payer status on treatment of cervical cancer at a tertiary referral center
Kimberly L. Levinson et al.
GYNECOLOGIC ONCOLOGY (2011)
Measuring clinically significant chemotherapy-related toxicities using medicare claims from cancer and leukemia group B (CALGB) trial participants
Elizabeth B. Lamont et al.
MEDICAL CARE (2008)
Patterns of use of chemotherapy for breast cancer in older women: Findings from Medicare claims data
XL Du et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
